相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inter- and Intra-individual Variation, and Limited Prognostic Utility, of Serum Alkaline Phosphatase in a Trial of Patients With Primary Sclerosing Cholangitis
Palak J. Trivedi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model
Philipp Schwabl et al.
BIOMEDICINES (2021)
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH
Rohit Loomba et al.
HEPATOLOGY (2021)
Cilofexor, a NonsteroidalFXRAgonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial
Keyur Patel et al.
HEPATOLOGY (2020)
Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities
Mette Vesterhus et al.
JOURNAL OF GASTROENTEROLOGY (2020)
Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry
Alexander Kuo et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease
Andrew J. Muir et al.
HEPATOLOGY (2019)
Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies
Brian M. Fung et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Identifying research priorities in primary sclerosing cholangitis: Driving clinically meaningful change from the patients' perspective
Martine Walmsley et al.
JOURNAL OF HEPATOLOGY (2019)
British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis
Michael Huw Chapman et al.
GUT (2019)
The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis
Michael Trauner et al.
HEPATOLOGY (2019)
Primary Sclerosing Cholangitis and Psychological Wellbeing: A Scoping Review
Veronica Ranieri et al.
SEMINARS IN LIVER DISEASE (2019)
Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation
Iris C. Steenstraten et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Endpoints in the design of clinical trials for primary sclerosing cholangitis
Cyriel Y. Ponsioen
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Development and validation of a primary sclerosing cholangitis-specific patient-reported outcomes instrument: The PSC PRO
Zobair M. Younossi et al.
HEPATOLOGY (2018)
Quality of life and primary sclerosing cholangitis: The business of defining what counts
Katherine Arndtz et al.
HEPATOLOGY (2018)
The evolution of natural history of primary sclerosing cholangitis
Will R. Takakura et al.
CURRENT OPINION IN GASTROENTEROLOGY (2017)
Validation of the Prognostic Value of Histologic Scoring Systems in Primary Sclerosing Cholangitis: An International Cohort Study
Elisabeth M. G. de Vries et al.
HEPATOLOGY (2017)
Primary sclerosing cholangitis - a comprehensive review
Tom H. Karlsen et al.
JOURNAL OF HEPATOLOGY (2017)
Outcomes of liver retransplantation in patients with primary sclerosing cholangitis
Jacqueline B. Henson et al.
LIVER TRANSPLANTATION (2017)
Surrogate Endpoints for Clinical Trials in Primary Sclerosing Cholangitis: Review and Results From an International PSC Study Group Consensus Process
Cyriel Y. Ponsioen et al.
HEPATOLOGY (2016)
Primary Sclerosing Cholangitis
Konstantinos N. Lazaridis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis
Mette Vesterhus et al.
HEPATOLOGY (2015)
Baseline Values and Changes in Liver Stiffness Measured by Transient Elastography Are Associated With Severity of Fibrosis and Outcomes of Patients With Primary Sclerosing Cholangitis
Christophe Corpechot et al.
GASTROENTEROLOGY (2014)
Radiologic Course of Primary Sclerosing Cholangitis: Assessment by Three-Dimensional Magnetic Resonance Cholangiography and Predictive Features of Progression
Ana Ruiz et al.
HEPATOLOGY (2014)
Primary sclerosing cholangitis
Gideon M. Hirschfield et al.
LANCET (2013)
Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review
Kirsten Boonstra et al.
JOURNAL OF HEPATOLOGY (2012)
Diagnosis and Management of Primary Sclerosing Cholangitis
Roger Chapman et al.
HEPATOLOGY (2010)
EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
Ulrich Beuers et al.
JOURNAL OF HEPATOLOGY (2009)
Bile acids: regulation of synthesis
John Y. L. Chiang
JOURNAL OF LIPID RESEARCH (2009)
High-dose ursodeoxycholic acid in primary sclerosing cholangitis:: A 5-year multicenter, randomized, controlled study
R Olsson et al.
GASTROENTEROLOGY (2005)
Surrogate endpoints and FDA's accelerated approval process
TR Fleming
HEALTH AFFAIRS (2005)
Farnesoid X receptor responds to bile acids and represses cholesterol 7α-hydroxylase gene (CYP7A1) transcription
JYL Chiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
